CCCC vs IP · rev $35.6M vs P/E 43, $26.62B cap
C4 Therapeutics Inc (CCCC) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
IP does not have a complete income-statement cache yet.
CCCC currently screens at market cap $425.7M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the CCCC and IP stock pages for the full models.
Not investment advice.